欧洲药典适用性证书数据库
(Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM)
专论编号 物质名称 证书持有人 持有人ORG-ID和LOC-ID 证书编号 发布日期 证书状态 到期续期 证书结束日期 证书类型 上一程序的结束日期 历史数据
程序类型|结论|日期
2258 Olanzapine JUBILANT BIOSYS LIMITED Nanjangud IN 100055198;100098088 CEP 2011-030 - Rev 02 2025/09/04 Valid Chemical 2025/09/04 Notification|CEP granted|04/09/2025;
Minor revision|Accepted - CEP remains valid|28/03/2024;
Major revision|CEP granted|12/10/2022;
Minor revision|Rejected|26/07/2022
2288 Citalopram hydrobromide JUBILANT BIOSYS LIMITED Nanjangud IN 100055198;100098088 CEP 2009-175 - Rev 06 2025/09/04 Valid Chemical 2025/09/04 Notification|CEP granted|04/09/2025;
Notification|CEP granted|10/07/2023;
Notification|CEP granted|11/08/2022;
Minor revision|CEP granted|23/06/2021;
Notification|Rejected|07/05/2021;
Major revision|CEP granted|18/05/2020
2173 Gabapentin HETERO DRUGS LIMITED Hyderabad IN 100008415;100014434 CEP 2013-167 - Rev 04 2025/09/04 Valid Chemical 2025/09/04 Minor revision|CEP granted|04/09/2025;
Minor revision|CEP granted|08/07/2024;
Minor revision|CEP granted|20/09/2023;
Minor revision|CEP granted|30/08/2022
1681 Tramadol hydrochloride JUBILANT BIOSYS LIMITED Nanjangud IN 100055198;100098088 CEP 2002-199 - Rev 08 2025/09/04 Valid Chemical 2025/09/04 Notification|CEP granted|04/09/2025;
Major revision|Accepted - CEP remains valid|23/08/2024;
Notification|CEP granted|11/08/2022;
Minor revision|Accepted - CEP remains valid|21/05/2021
1559 Risperidone, 'RIS' JUBILANT BIOSYS LIMITED Nanjangud IN 100055198;100098088 CEP 2006-046 - Rev 04 2025/09/04 Valid Chemical 2025/09/04 Notification|CEP granted|04/09/2025;
Notification|CEP granted|23/08/2022
203 Polymyxin B sulfate HEBEI SHENGXUE DACHENG PHARMACEUTICAL CO. LTD. Shijiazhuang City CN 100016575;100025368 CEP 2024-389 - Rev 00 2025/09/03 Valid 03/09/2030 Chemical 2025/09/03 New application|CEP granted|03/09/2025
1012 Famotidine SMS LIFESCIENCES INDIA LIMITED Hyderabad IN 100039495;100077080 CEP 2023-455 - Rev 00 2025/09/03 Valid 03/09/2030 Chemical 2025/09/03 New application|CEP granted|03/09/2025
653 Baclofen PCAS Ecully FR 100011754;100054740 CEP 2003-247 - Rev 02 2025/09/02 Valid Chemical 2025/09/02 Monograph revision|CEP granted|02/09/2025;
Notification|Accepted - CEP remains valid|03/06/2021;
Notification|CEP granted|30/07/2020
49 Paracetamol GRANULES INDIA LIMITED Hyderabad IN 100011671;100097387 CEP 1998-047 - Rev 07 2025/09/02 Valid Chemical 2025/09/02 Notification|CEP granted|02/09/2025;
Minor revision|Accepted - CEP remains valid|28/04/2023;
Minor revision|Accepted - CEP remains valid|28/10/2022;
Monograph revision|Accepted - CEP remains valid|23/03/2022;
Minor revision|Accepted - CEP remains valid|26/11/2021;
Minor revision|Accepted - CEP remains valid|10/09/2021;
Minor revision|Accepted - CEP remains valid|18/06/2020
731 Naproxen ZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD Xianju CN 100011826;100018693 CEP 2006-270 - Rev 03 2025/09/02 Valid Chemical 2025/09/02 Minor revision|CEP granted|02/09/2025;
Notification|Accepted - CEP remains valid|10/11/2023;
Notification|Accepted - CEP remains valid|06/01/2022;
Minor revision|Accepted - CEP remains valid|26/06/2020
464 Amitriptyline hydrochloride R.L. FINE CHEM PRIVATE LIMITED Chikkaballapur IN 100016723;100053383 CEP 2004-214 - Rev 06 2025/09/02 Valid Chemical 2025/09/02 Notification|CEP granted|02/09/2025;
Minor revision|CEP granted|03/04/2024
1745 Carvedilol ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański PL 100000470;100001572 CEP 2002-258 - Rev 09 2025/09/02 Valid Chemical 2025/09/02 Minor revision|CEP granted|02/09/2025;
Major revision|CEP granted|22/10/2021;
Minor revision|CEP granted|22/01/2021
1756 Lamotrigine JUBILANT BIOSYS LIMITED Nanjangud IN 100055198;100098088 CEP 2009-162 - Rev 03 2025/09/02 Valid Chemical 2025/09/02 Notification|CEP granted|02/09/2025;
Notification|CEP granted|12/08/2022
2577 Oxcarbazepine JUBILANT BIOSYS LIMITED Nanjangud IN 100055198;100098088 CEP 2014-059 - Rev 04 2025/09/02 Valid Chemical 2025/09/02 Notification|CEP granted|02/09/2025;
Minor revision|CEP granted|02/04/2025;
Minor revision|CEP granted|14/10/2024;
Major revision|Accepted - CEP remains valid|18/03/2024;
Minor revision|Accepted - CEP remains valid|28/10/2022;
Notification|Rejected|04/10/2022;
Notification|CEP granted|11/08/2022;
Notification|Accepted - CEP remains valid|27/08/2020;
Renewal|CEP granted|18/05/2020
50 Procaine Hydrochloride, Process H CHONGQING SOUTHWEST No.2 PHARMACEUTICAL FACTORY CO., LTD. Chongqing CN 100014817;100023402 CEP 2024-577 - Rev 00 2025/09/02 Valid 02/09/2030 Chemical 2025/09/02 New application|CEP granted|02/09/2025
615 Guaifenesin, BPL site GRANULES INDIA LIMITED Hyderabad IN 100011671;100097387 CEP 2021-332 - Rev 01 2025/09/02 Valid 10/12/2026 Chemical 2025/09/02 Notification|CEP granted|02/09/2025;
Minor revision|Accepted - CEP remains valid|06/07/2022;
New application|CEP granted|10/12/2021
2191 Atorvastatin calcium, Process-II AMOLI ORGANICS PRIVATE LIMITED Mumbai IN 100016500;100025303 CEP 2025-318 - Rev 00 2025/09/02 Valid 02/09/2030 Chemical 2025/09/02 New application|CEP granted|02/09/2025
2598 Levofloxacin hemihydrate MSN LIFE SCIENCES PRIVATE LIMITED Medak IN 100018316;100027671 CEP 2021-016 - Rev 01 2025/09/02 Valid 22/08/2028 Chemical 2025/09/02 Minor revision|CEP granted|02/09/2025;
New application|CEP granted|22/08/2023
931 Metformin Hydrochloride, BPL Site GRANULES INDIA LIMITED Hyderabad IN 100011671;100097387 CEP 2018-120 - Rev 02 2025/09/02 Valid Chemical 2025/09/02 Notification|CEP granted|02/09/2025;
Renewal|CEP granted|12/12/2023;
Minor revision|Accepted - CEP remains valid|25/11/2022;
Minor revision|Accepted - CEP remains valid|22/09/2020;
Monograph revision|Accepted - CEP remains valid|24/03/2020
2154 Telmisartan, Process IV, micronised and non-micronised ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou CN 100011833;100018698 CEP 2023-181 - Rev 01 2025/09/01 Valid 03/04/2029 Chemical 2025/09/01 Minor revision|CEP granted|01/09/2025;
Notification|Accepted - CEP remains valid|11/07/2024;
New application|CEP granted|03/04/2024

数据库说明:

当前数据更新日期:2025年12月21日。
©2006-2025 DrugFuture->Certificates of Suitability to the monographs of European Pharmacopoeia, EDQM